UBE2Q1-AS1

Across TCGA pan-cancer cohorts, UBE2Q1-AS1 RNA differs between tumor and matched normal tissue in 12 of 18 cancer types tested, making tumor–normal expression one of UBE2Q1-AS1’s most consistent transcriptional readouts.

The strongest signal is observed in bladder urothelial carcinoma (BLCA), where UBE2Q1-AS1 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types UBE2Q1-AS1 is over-expressed in tumor.

BLCA, HNSC, and COAD are the cancer types where UBE2Q1-AS1 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in UBE2Q1-AS1 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
BLCA	Male	All	+0.875	<.001	10	view →
HNSC	All	III,IV	+0.328	<.001	10	view →
COAD	Male	II,III,IV	+0.711	<.001	9	view →
KIRC	All	All	+0.334	<.001	9	view →
LUAD	Female	All	+0.647	<.001	8	view →
BRCA	All	II,III,IV	+0.467	<.001	6	view →
LUSC	All	All	+0.519	<.001	5	view →
LIHC	All	All	+0.166	<.001	5	view →
CHOL	All	All	+1.741	<.001	4	view →
STAD	All	All	+0.516	<.001	4	view →
READ	All	All	+0.911	.006	2	view →
ESCA	All	All	+0.637	.008	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 12 strongest of 12 lineages.

UBE2Q1-AS1–BLCA

Open the BLCA breakdown →